We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Uber
UBER
$157B
| $116M | 0.22% |
1,238,951
+565,639
| +84% | +$46.6M |
|
127
Live Nation Entertainment
LYV
$41.8B
| $114M | 0.22% |
756,349
+84,375
| +13% | +$11.6M |
|
128
UGI
UGI
$8.19B
| $114M | 0.21% |
3,132,747
-759,256
| -20% | -$26.1M |
|
129
Blue Owl Capital
OWL
$8.31B
| $113M | 0.21% |
5,877,700
-1,023,800
| -15% | -$18.9M |
|
130
Advance Auto Parts
AAP
$2.6B
| $111M | 0.21% |
2,387,325
+1,028,561
| +76% | +$41.2M |
|
131
State Street
STT
$53.2B
| $111M | 0.21% |
1,042,794
+43,379
| +4% | +$4.01M |
|
|
VRNA
132
DELISTED
Verona Pharma
VRNA
| $108M | 0.2% |
1,146,095
-121,666
| -10% | -$9.01M |
|
133
Rubrik
RBRK
$21.9B
| $108M | 0.2% |
1,208,292
-308,699
| -20% | -$24.4M |
|
134
Allstate
ALL
$65.2B
| $108M | 0.2% |
537,496
+232,250
| +76% | +$46.3M |
|
135
NRG Energy
NRG
$24B
| $108M | 0.2% |
673,152
+313,482
| +87% | +$41.3M |
|
136
Generac Holdings
GNRC
$11.8B
| $107M | 0.2% |
749,347
+291,012
| +63% | +$35.5M |
|
137
Genuine Parts
GPC
$19.1B
| $107M | 0.2% |
+882,160
| New | +$106M |
|
138
Ulta Beauty
ULTA
$22.9B
| $107M | 0.2% |
228,545
+15,370
| +7% | +$6.36M |
|
139
Rhythm Pharmaceuticals
RYTM
$7.8B
| $107M | 0.2% |
1,686,494
+94,623
| +6% | +$5.79M |
|
140
S&P Global
SPGI
$129B
| $106M | 0.2% |
201,604
-1,244
| -0.6% | -$621K |
|
141
Alnylam Pharmaceuticals
ALNY
$31.2B
| $106M | 0.2% |
323,842
+59,669
| +23% | +$16.5M |
|
142
Texas Roadhouse
TXRH
$13.2B
| $104M | 0.2% |
555,871
+65,935
| +13% | +$11.8M |
|
143
Cloudflare
NET
$108B
| $103M | 0.19% |
527,134
+336,679
| +177% | +$48.9M |
|
144
UiPath
PATH
$9.47B
| $103M | 0.19% |
8,048,321
+2,328,225
| +41% | +$27.9M |
|
145
Klaviyo
KVYO
$5.52B
| $97.8M | 0.18% |
2,911,007
+241,207
| +9% | +$7.64M |
|
146
IDEAYA Biosciences
IDYA
$4.03B
| $97.3M | 0.18% |
4,627,266
-140,660
| -3% | -$2.7M |
|
147
TransDigm Group
TDG
$65.9B
| $97M | 0.18% |
63,758
+16,925
| +36% | +$23.8M |
|
148
CrowdStrike
CRWD
$226B
| $95.8M | 0.18% |
752,624
-301,392
| -29% | -$32.7M |
|
149
Best Buy
BBY
$17.6B
| $95.7M | 0.18% |
1,425,769
-239,459
| -14% | -$16.3M |
|
150
NetApp
NTAP
$37.1B
| $95.2M | 0.18% |
893,832
-202,404
| -18% | -$19.2M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.